Predictors of the intention to receive the COVID 19 vaccine by Iranians 18– 70 year old: Application of health belief model
نویسندگان
1 Department of Health Education and Health Promotion, School of Health, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
2
3 Department of Epidemiology and Biostatistics, School of Medicine, Occupational Environment Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
4 Department of Health Education and Health Promotion, School of Health, Occupational Environment Research Centre, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
doi
چکیده
BACKGROUND: In terms of public health, vaccination is considered as the most effective approachagainst the infectious diseases. Accepting and receiving the first vaccine produced as an innovationmay not be easy. Therefore, the present study was conducted to investigate the predictors of intentionto receive COVID‑19 vaccine by Iranians aged 18–70 years based on the health belief model in 2021.MATERIALS AND METHODS: This descriptive study was performed on 2365 people aged18–70‑year old in Iran by random cluster sampling. Receipt of data was done electronicallyquestionnaire through the Porcelain system. Data were analyzed using SPSS software version 20using Chi‑square, one‑way analysis of variance, independent t‑test, and multiple regression analysisat a significance level of 0.05.RESULTS: The mean score of receiving the Iranian corona vaccine was 3.06 ± 1.30 out of 5 points.About 16.7% reported that they will definitely choose the Iranian vaccine. The highest correlationwas between the intention to receive the vaccine with self‑efficacy (r = 0.239, P < 0.001) and barriersto receiving the vaccine (r = −0.237, P < 0.001). Self‑efficacy (β = 0.114, P < 0.001), perceivedbarriers (β = −0.126, P < 0.001), and benefits of vaccine (β = 0.061, P = 0.022) were most importantpredictors the intention to receive the vaccine.CONCLUSION: Approximately 38% reported that they would definitely and probably not choose theIranian corona vaccine. Therefore, it is suggested that more information should be provided aboutthe features and benefits of domestically produced vaccines compared to foreign products.
